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ABSTRACT 
The BCL-2 family members are key regulators of the intrinsic apoptotic pathway, which is defined by 
permeabilisation of the mitochondrial outer membrane by members of the BAX-like subfamily. BOK 
is classified as a BAX-like protein; however, its (patho-)physiological role remains largely unclear. 
We therefore assessed the membrane permeabilisation potential of C-terminally truncated 
recombinant BOK, BOK∆C. We show that BOK∆C can permeabilize liposomes mimicking the 
composition of mitochondrial outer membrane, but not of endoplasmic reticulum, forming large and 
stable pores over time. Importantly, pore formation was enhanced by the presence of cBID and 
refractory to the addition of anti-apoptotic BCL-XL. However, isolated mitochondria from Bax-/-Bak-/- 
cells were resistant to BOK-induced cytochrome c release, even in presence of cBID. Taken together, 
we show that BOK∆C can permeabilize liposomes, and cooperate with cBID, but its role in directly 
mediating mitochondrial permeabilisation is unclear and may underlie a yet to be determined negative 
regulation. 
  
 
INTRODUCTION 
The members of the BCL-2 family are critical regulators of the intrinsic apoptotic pathway, which is 
defined by mitochondrial outer membrane permeabilisation (MOMP). The members of the family 
contain up to four short conserved BCL-2 homology domains (BH1-4) and are subdivided into the 
pro-apoptotic BH3-only proteins or the multi-BH domain members. The latter comprises the 
prosurvival BCL-2-like group (BCL-2, MCL-1, BCL-XL and BFL-1/A1) and the pro-apoptotic BAX-
like group (BAX, BAK and maybe BOK) [1].  
Currently, it is accepted that in the absence of cellular stress these proteins co-exist in a network of 
balanced interactions, neutralizing each other in their functions. Upon metabolic, pathogen- or 
damage-induced cellular stress, the network is altered resulting in apoptotic cell death or survival, 
depending on the magnitude of the insult. During apoptosis, MOMP is promoted by the 
oligomerization of BAX and/or BAK resulting in the release to the cytosol of apoptogenic proteins 
from the mitochondrial intermembrane, including cytochrome c and SMAC/DIABLO, with 
subsequent activation of caspases [2]. A pre-requisite for MOMP is the disengagement of BAK from 
anti-apoptotic MCL-1 and BCL-XL, as well as recruitment of cytosolic BAX to the MOM [3]. A well-
known factor aiding BAX translocation and mitochondrial pore formation is the p15 fragment of the 
BH3-only protein BID [4]. BID is proposed to interact transiently with BAX, promoting the 
conformational changes for BAX membrane insertion in a catalyst-like manner [4].   Importantly, the 
lipid composition of the membranes where these proteins exert their activities provide an extra layer 
of complexity [5, 6]. Cardiolipin, a mitochondria-specific phospholipid, seems crucial for the 
concerted activity of cBID and BAX [7-10].   
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BCL-2-related ovarian killer (BOK, gene name BOK or BCL2L9) is a 23.4 kDa protein highly 
conserved in the animal kingdom, with sequence homology to BAK and BAX [11]. In contrast to 
BAX or BAK, BOK predominantly localizes to the membranes of the endoplasmic reticulum (ER) 
and the Golgi apparatus, and to a lesser extent to mitochondria [12]. BOK is widely expressed and 
readily detectable at protein level in mouse tissues, with high expression in reproductive tissues, brain, 
kidney, spleen and gastrointestinal tract [12, 13]. BOK function in cells is enigmatic. Although 
enforced expression of BOK induces apoptosis [11, 12, 14, 15], genomic deletion of Bok/Bak or 
Bok/Bax did not produce an enhanced phenotype beyond that accounted for Bax or Bak single 
knockout mice, with the exception of increased oocyte numbers in Bok-/-Bax-/- females [16]. Recent 
work from Ke et al. on a chimeric mouse with a Bok-/-Bak-/-Bax-/- triple knockout hematopoietic 
system provided evidence that BOK’s redundancy with BAX and BAK exists but might be restricted 
to specific tissues [17]. However, other studies suggest that depending on the tissue or the nature of 
the apoptotic stressor, BOK may have non-apoptotic functions, such as in trophoblast proliferation 
[18], or may even have a pro-survival function [12, 19]. 
BOK has been shown to interact with IP3 receptors, protecting IP3Rs from caspase-mediated 
degradation and BOK from proteasomal degradation [20, 21]. Degradation of BOK via the 
ubiquitin/proteasome was also shown by Llambi et al. in the context of the ERAD pathway [14]. This 
paper also describes a BAX-like apoptosis inducing function of BOK when the ERAD pathway is 
blocked [14].  
In this work, we generated an untagged, C-terminally truncated version of recombinant BOK 
(BOK∆C), and characterized its pore forming potential in liposomes and isolated mitochondria. BOK∆C 
provoked the permeabilisation of artificial membranes by forming long-lived toroidal pores, large 
enough for passage of a 104 kDa protein. BOK∆C ’s induced pore formation strongly depended on the 
lipid composition, with liposomes resembling MOM being much more efficiently permeabilized than 
those mimicking ER composition. Importantly, we provide solid evidence that cleaved BID (cBID) 
cooperates with BOK∆C in pore formation, while BCL-XL was unable to inhibit BOK∆C activity. 
Strikingly, however, our studies on mitochondria isolated from Bax-/-Bak-/- cells indicated that BOK∆C 
is highly inefficient in promoting MOMP, even in the presence of cBID or after heat activation. 
Overall, these data indicate that despite its effects on artificial membranes, the role of BOK on 
biological membranes may be subject to yet to be described negative regulatory mechanisms.  
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RESULTS 
Purification of recombinant BOK∆C  
BCL-2 proteins have been purified in the past by affinity-based methodologies using histidine or GST 
tag-based approaches. Tagged proteins come with the risk of introducing artifacts. One notable 
exception is the purification of full length BAX and BCL-XL in bacteria using an intein-chitin binding 
domain fused to their C-terminus [22, 23]. The intein domain can be subsequently removed by 
addition of dithiothreitol, releasing the untagged protein with a high purity degree in one step. Based 
on these advantages we decided to use the same approach to produce recombinant BOK and its C-
terminally truncated form, BOK∆C. A major pitfall while establishing the purification workflow was 
the amount of contaminants present in the elution from the chitin-affinity step. One explanation would 
lie in the acidic nature of the E. coli proteome [24, 25] contrasting with the high isoelectric point (pI) 
of BOK, which seems unique amongst the multidomain members of the BCL-2 family (Figure 1A), 
thus favoring the binding of unwanted proteins. To overcome this effect, we incorporated a cation 
exchange step while working at high salt concentration and pH. This method has been reported to 
outperform those using Ni-NTA and GST for the purification of basic proteins [26]. The purified full 
length BOK did not reach an acceptable purity and the total yield was extremely low, likely due to 
protein aggregation because of its hydrophobic C-terminal tail. On the other hand, significantly higher 
amounts (300-700 µg protein from 5 L culture) of pure (>90%) BOK∆C could be purified, which is 
comparable to the purification of BAX (Figure 1B-D). Therefore, we decided to work with BOK∆C. 
The identity of the purified protein was assessed using western blotting and mass spectrometry 
(Figure 1C and data not shown). 
 
BOK∆C induces membrane permeabilisation of large unilamellar vesicles depending on the lipid 
composition 
We hypothesized that BOK follows a similar mechanism of action as BAX and BAK when interacting 
with membranes. Thus, we explored the potential of recombinant BOK∆C to promote membrane 
permeabilisation, by following content release of the fluorophore calcein (~1 kDa) from large 
unilamellar vesicles (LUVs). Since BOK, under physiological conditions, is largely localized to the 
membranes of the ER [12], we reasoned that BOK might differentially affect artificial membranes 
mimicking ER or MOM lipid composition. Indeed, LUVs made from a mitochondria-like lipid 
mixture (MITOmix) were readily permeabilized, in contrast to those resembling an ER lipid 
composition (ERmix), which required much higher protein concentrations to reach comparable 
permeabilisation levels (Figure 2A).  
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A major difference in those membrane model compositions was the presence of the mitochondria-
specific lipid cardiolipin in MITOmix while it was absent from ERmix. Hence, we decided to test the 
contribution of this lipid to the BOK∆C -induced calcein release. As shown in Figure 2B, the CL 
content positively correlated with BOK∆C -induced calcein release from LUVs.  
Cardiolipin is a negatively charged phospholipid inducing intrinsic monolayer curvature that has been 
suggested to play a specific role in BAX pore formation [8]. To find out whether this is also the case 
for BOK∆C, or whether it is a general charge effect, we substituted CL for phosphatidylglycerol (PG) 
(Figure 2B). When a similar proportion of PG was used in the assay, the dye release was similar, 
suggesting that the overall negative charge of the membrane plays a role in the pore activity of 
BOK∆C. 
 
The pores formed by BOK∆C show features of toroidal pores 
Several lines of evidence suggest that BAX and BAK form toroidal pores, which involve the 
participation of lipids at the pore edge. Consequently, these pores would be affected by lipids 
modulating the intrinsic membrane curvature. The formation of non-lamellar structures, like toroidal 
pores, frequently requires the presence of lipids with opposite geometrical and intrinsic curvature 
properties to compensate the defective packaging in the pore rim [27]. To investigate the impact of the 
lipid geometry on BOK∆C -induced membrane permeabilisation, we varied the concentrations of CL 
(cone, negative curvature inducer) and lysophospatidylcholine (LPC) (inverted cone, positive 
curvature inducer). Surprisingly, even small amounts of LPC enabled BOK∆C -mediated calcein 
release to a degree comparable to that obtained using 20% of CL (Figure 2C). This effect was further 
enhanced when CL and LPC were combined in the same vesicles, in line with the idea that BOK∆C 
could be involved in the formation of non-lamellar structures like toroidal pores. However, we could 
not discard the possibility that the role of CL was merely due to its negative curvature. To corroborate 
this, we included phosphatidic acid (PA) in our analysis, which is a lipid that combines negative 
charge and a very pronounced negative curvature. Indeed, from all the binary lipid mixtures tested, 
those containing PA exhibited the highest sensitivity to BOK∆C treatment (Figure 2D). Additionally, 
we also used cholesterol, which is a neutral lipid with a high negative curvature; indeed, addition of 
cholesterol also increased BOK∆C mediated dye release, although its impact was lower than that of 
LPC (Figure 2D). These results demonstrate that BOK∆C membrane activity largely depends on the 
presence of negatively charged lipids and on their intrinsic curvature, suggesting that BOK∆C pores are 
of toroidal nature. 
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cBID cooperates with BOK∆C to form pores that allow the passage of the 104 kDa protein APC 
Considering the concerted mechanism described for cBID to activate BAX to form pores in 
membranes [28], we tested if the membrane activity of BOK∆C would be modulated by cBID in a 
similar manner. Since BOK∆C could permeabilize LUVs of several lipid compositions, we choose the 
MITOmix for these experiments due to its physiological relevance and positive, but still moderate, 
reactivity to BOK∆C.  
We first determined the BOK∆C concentration that per se induced 50% of the maximum calcein 
release in the LUVs (7 nM, Figure 3A), which was then used together with serial dilutions of cBID to 
test for synergy. Surprisingly, cBID, but not its BH3 peptide nor a BIM BH3 peptide, clearly 
exacerbated the calcein release activity of BOK∆C (Figure 3B, C). Of note, cBID also clearly enhanced 
the calcein release activity of full length BOK (Figure 3B). 
At this point, we hypothesized that, similar to BAX, BOK∆C could promote the trespassing of 
molecules bigger than calcein (>1 kDa). To investigate the dimension of BOK∆C -mediated membrane 
pores, we used cell-sized vesicles known as giant unilamellar vesicles (GUV), composed of the 
MITOmix and a lipid dye to visualize the membrane. We incubated GUVs with two differently sized 
proteins: AlexaFluor-488 conjugated cytochrome c (cyt. c488; 12 kDa) and allophycocyanin (APC; 104 
kDa) and followed their passage through the membrane in presence or absence of cBID, or cBID plus 
BCL-XL. As positive and negative references we used cBID and BAX in presence or absence of BCL-
XL after incubation time of 60 minutes, as shown before [29, 30].  
Using the previous conditions in this membrane model, BOK∆C alone had negligible activity at 10 nM 
concentration, but the population of non-permeabilized GUVs was significantly reduced in the 
samples treated with BOK∆C and cBID. This effect was comparable to the positive control, BAX plus 
cBID (Figure 3D) and confirmed the cBID effect on BOK activity observed in the calcein assay. 
Interestingly, and contrasting with cBID/BAX, the permeabilisation of GUVs by cBID/BOK∆C was 
not inhibited by BCL-XL. Analysis of individual vesicles revealed that most were simultaneously 
filled with both dyes, indicating that the pores formed by BOK∆C plus cBID are permissive to 
molecules up to the size of 104 kDa (APC) (Figure 3E).  
 
BOK∆C-induced membrane permeabilisation can be accomplished by thermal activation 
A simplistic but still efficient approach described by Pagliari et al. used thermal activation of BAX 
and BAK to promote cyt. c release from isolated mitochondria [31]. A similar strategy has also been 
used to induce BAX oligomerization and pore formation on GUVs [29] and   LUVs [32]. After the 
robust permeabilisation induced by BOK∆C alone, we investigated the energetic threshold of this 
effect.  
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We co-incubated BOK∆C or BAX with MITOmix-derived GUVs for 45 min at 42°C and evaluated the 
permeabilisation to cyt. c488 and APC. As shown in Figure 4A, heat activated BOK (as well as BAX) 
facilitated the passage of both permeabilisation tracers into GUVs, indicating that cBID is not 
necessary for BOK∆C to form pores capable of accommodating a wide range of molecular sizes 
(Figures 4A, B) and that also in this aspect BOK activity is similar to BAX. 
 
BOK∆C forms long-lived pores 
After establishing the GUV permeabilisation potential by BOK∆C, we tested if BOK∆C pores were 
transient and unstable structures or if they remained stably open under equilibrium conditions. To 
address this question, we used an assay previously described [30, 33] in which two additional dyes of 
different size are added to GUVs preincubated with BCL-2 proteins that have induced pores. If the 
dyes are still able to enter the vesicles, this indicates that the membrane permeabilized state is stable 
at least during the incubation time. 
We incubated MITOmix-derived GUVs for 45 minutes with BOK∆C plus cBID in the presence of free 
AlexaFluor-555 (AF555) dye. Immediately after that we added cyt. c488 and APC to the wells and 
determined their incorporation into the vesicles within 15 min. This narrow time window guaranteed 
that vesicles filled with these proteins were most likely due to the existence of a pre-formed pore 
rather than to newly formed ones. Finally, the sample was imaged in order to detect whether cyt. c488 
and APC could also trespass the membrane through the formed pores (Figure 5A), which would be 
indicative of cBID/BOK∆C creating long-lived pores. Moreover, this experiment provides information 
about the pore size under equilibrium conditions and tests the impact of BOK∆C concentration on the 
pore size. 
The distribution of AF555 incorporation into GUVs was quantified (Figure 5B). As expected from the 
experiments shown above, GUV permeabilisation positively correlated with the amount of BOK∆C 
used. Interestingly, we noticed a decrease of GUVs per area, proportional to the concentration of 
BOK∆C (Figure 5C). We attribute this to the membrane destabilizing impact of the pore formation 
process, which, combined with the mechanical stress provided while adding the size markers, 
contribute to GUV destruction. A less pronounced, but still similar effect has been reported for BAX 
[30]. Afterwards, we focused on GUVs already filled with AF555, which indeed consistently 
incorporated cyt. c488 and APC. These results indicate that the initial pores remained permissive and 
stable during the time of the assay (Figures 5D, E). 
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BOK∆C is inefficient in releasing cyt. c from isolated mitochondria 
Since the membrane activity of BOK∆C was comparable to that of BAX, we next wanted to determine 
whether the BOK∆C pore-forming activity demonstrated in vitro had biological implications in the 
context of mitochondria. We explored if recombinant BOK∆C could mediate cyt. c release from 
mitochondria isolated from Bax-/-Bak-/- double deficient mouse embryo fibroblasts (MEF). Of note, 
and contrary to our findings in artificial lipid vesicles, BOK∆C was unable to permeabilize 
mitochondria, even in the presence of cBID (Figure 6A). Furthermore, we incubated Bax-/-Bak-/- 
mitochondria with BOK∆C at 43°C to recapitulate the heat activation process [31]. Surprisingly, and in 
contrast to BAX, BOK∆C was again unable to promote MOMP in those mitochondria (Figure 6B). 
Strikingly, this lack of activity in mitochondria is not the result of impaired interaction with the 
membrane, since we clearly detected association of BOKΔC with crude mitochondrial membranes 
isolated from Bok-/- cells (Figure 6C). This was also corroborated by sucrose gradient fractionation 
after co-incubation of BOKΔC with crude BOK-deficient mitochondrial fractions. In this case BOKΔC 
adopted a uniform distribution gradient not restricted to the mitochondria containing fractions, 
irrespective of the addition of cBID (Figure 6 D).  
DISCUSSION 
BOK remains an enigmatic and controversial protein among the BCL-2 members. In accordance with 
its sequence homology with BAX/BAK, multiple studies, including our own work, demonstrated that 
BOK promotes intrinsic apoptosis upon overexpression [11, 12, 14, 34]. However, both BAX/BAK-
dependent as well as BAX/BAK-independent mechanisms have been proposed since [12, 14, 34]. 
Currently, there is limited evidence for a pro-apoptotic role for BOK under physiological and 
pathophysiological conditions, and several studies even point towards protective roles of BOK in 
certain tissues or in response to specific stressors [12, 13, 16-19, 34-36].  
We describe an approach to purify recombinant BOK from bacteria, combining affinity and ion 
exchange-based techniques. In our exploratory experiments, we used full length BOK, and detected 
comparable pore activity to the truncated protein (data not shown). However, we could not exclude 
that the insertion of the transmembrane region simply following thermodynamic principles was 
responsible for this effect. Thus, we decided to use an untagged, truncated version lacking the last 24 
amino acids (BOK∆C24, [12]), which resulted also in higher yields and purity.  
Interestingly, BOK seems to predominantly localize to the membranes of the ER, where it interacts 
with IP3 receptors, and where it is subject to ubiquitylation and proteasomal turnover [12, 14, 20, 21]. 
In spite of this, addressing the question whether BOK can permeabilize the mitochondrial outer 
membrane and induce MOMP in a manner similar to BAX/BAK seems absolutely critical to better 
understand the role and function of BOK. In a recent study, Llambi and colleagues have provided 
evidence that recombinant BOK (more precisely an 8xHis-tagged, C-terminally truncated version) can 
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have pore-forming activity in liposomes, which, intriguingly, does not seem to require cooperation 
with activator BH3-only proteins (e.g. tBID) [14]. However, the ability to permeabilize membranes 
has also been reported for other BCL-2 proteins, like BCL-XL, BCL-2 or cBID, with lack of 
correlation regarding a direct function in MOMP and therefore caution is advised with the 
interpretation of simple experiments of liposome permeabilisation. 
In this work, we analyzed in detail the pore forming potential of recombinant BOK∆C in artificial 
liposomes and isolated mitochondria. We confirmed the recently described ability of BOK∆C to 
permeabilize artificial membranes on its own [14] and demonstrate that the main features of BOK 
pore activity resemble those of BAX and BAK. The lipid composition of biomembranes strongly 
defines critical physicochemical properties like overall charge, intrinsic curvature and fluidity. A 
concerted interplay of these parameters with membrane proteins guarantees important physiological 
processes e.g. membrane fission and fusion, organelle shape or protein-lipid segregation in 
microdomains [37]. Our data from calcein assays indicated that BOK∆C permeabilized vesicles in 
function of their overall negative charge and greatly depending on the intrinsic curvature of those 
membranes. This link on lipid composition and activity of BCL-2 proteins has been documented as a 
key determinant of BAX, BAK, BIM and BID activities [5, 9, 10].  
Further evaluation of BOK∆C -mediated pores in GUVs indicated that they have sufficient size to 
allow the passage of large proteins like cyt. c and APC, and that those pores remain stable over time, 
resembling those described for BAX [23]. This, together with the large dependence on lipid geometry, 
strongly suggests that the membrane pores induced by BOK are toroidal. As with BAX, our data 
support the participation of lipids in the pore structure as well as the formation of flexible, undefined 
pores that reach large sizes and remain open for a long time. Additional studies will be required to 
elucidate if BOK pores are also tunable in size [30] and correlate with a mixture of BOK oligomeric 
species [32], as well as if arc- and/or ring-like assemblies of BOK line the pore walls [38]. 
Importantly, however, and in contrast to BAX plus cBID, BOK or BOK plus cBID induced pores 
independently of the presence of BCL-XL. 
Of note, we demonstrate here that cBID, but not its derived BH3-peptide, cooperates with BOK∆C to 
induce permeabilisation of artificial membranes modeling the mitochondrial lipid composition. This 
cooperation was noticeable beyond the point of equimolarity between the proteins, suggesting that 
cBID is less efficient in promoting BOK activity than in activating BAX. This result contrasts with 
the data provided by Llambi et al [14] who concluded that BOK is constitutively active, 
independently of the influence of activator BH3-only proteins, or any other BCL-2 protein. Whereas 
we used untagged BOK∆C, Llambi et al. used an 8xHis-tagged BOK∆C, which was then artificially 
aggregated using Ni-NTA. It is conceivable to speculate that Ni-NTA may very strongly activate 
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BOK, thereby masking a possible cooperative effect by BH3-only peptides. Importantly, we further 
provide evidence that cBID also cooperates with full length BOK.  
We also report that the pore activity of cBID/ BOK∆C is not inhibited by BCL-XL. This is unexpected, 
as based on the literature, BCL-XL should sequester cBID, thereby preventing the activation of 
BOK∆C. We speculate that the interaction between cBID and BOK∆C induces conformational changes 
hindering the interaction between cBID and BCL-XL. A direct inhibition of BOK∆C by BCL-XL on the 
other hand seems unlikely, as others and we have failed to show interaction between these two 
proteins [11, 12, 39]. Considering the “helix-loop-helix” secondary structure of BOK and its pore-
forming activity, we hypothesized that cBID function could be substituted by administration of heat. 
The incubation of BOK∆C and BAX with mildly increased temperatures indeed provided enough 
energy to induce conformational changes responsible for their insertion in the lipid bilayer. 
Interestingly, in cells stressed by heat, BAX undergoes conformational changes, translocation to the 
mitochondria and apoptosis characterized by a significant calcium dyshomeostasis [40]. A thrilling 
possibility emerging form this stress model is that BOK might be also activated by the treatment, thus 
compromising the calcium homeostasis in the cell during the cell death. 
An intriguing result from our work is that, despite of all the above in vitro evidence of BOK∆C being 
able to permeabilize artificial membranes, we did not find evidence for BOK∆C -mediated cytochrome 
c release from enriched mitochondrial fractions derived from Bax-/-Bak-/- MEFs, not even when cBID 
was added or heat was provided to the reaction mixture. This result contrasts with reports that BOK 
can trigger the intrinsic apoptotic pathway independently of BAX/BAK [14, 34]. However, neither of 
those studies provided direct proof of cytochrome c release by recombinant BOK on isolated 
mitochondria. Our data indicate that the activity of BOK∆C in biological membranes might be 
subjected to important negative regulatory steps or factors overlooked in our assay that deserve 
further investigation. It remains further possible that, despite its in vitro pore-forming potential, 
BOKΔC fails to remodel the mitochondria outer membrane in a way compatible with the release of 
cytochrome c from the intermembrane space. Additionally, we cannot ignore the possibility that BOK 
might need its C-terminal tail-anchor for its full activity in mitochondria, despite reports that the C-
terminus does not seem to be necessary for BAK [31, 41] or BAX [42, 43] to release cyt. c from 
isolated mitochondria. 
Given that BOK does not dominantly localize to mitochondria and that it does not efficiently release 
cytochrome c from them when isolated and in the absence of BAX/BAK, we cannot discard the 
possibility that MOMP-induction may not be the main function of BOK. Considering the nature of the 
effects when BOK interacts with membranes, it seems conceivable that one main function of BOK 
could be related with the stabilization of regions of high membrane curvature, which may include 
non-lamellar structures and membrane pores. Since most BOK is located at the ER, where it has been 
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shown to interact with IP3R and maybe to play a role in calcium homeostasis, one possibility might 
be that BOK acts at the ER/mitochondrial contact sites. These sites are responsible for calcium 
exchange between ER and mitochondria, are enriched in IP3R and likely involve special membrane 
structures that allow lipid exchange. The presence of BOK at these sites may also allow their 
regulation by cBID during apoptosis. Although our work sheds light on the molecular mechanism of 
BOK at the membrane and opens new research possibilities, additional efforts will be required to 
connect the mechanism of action of BOK with its biological function.  
Taken together, we show that BOK∆C forms large and stable pores in model membranes, and that 
BOK∆C (and likely full length BOK) activity is cooperatively enhanced by cBID but not blockable by 
BCL-XL. However, cytochrome c release from isolated BAX/BAK-deficient mitochondria by BOK∆C 
(with or without cBID) was inefficient compared to BAX/cBID. Although the membrane activity of 
both proteins in model membranes is very similar, the latter observation clearly distinguishes the 
properties of BOK∆C from those of BAX (and BAK).   
 
EXPERIMENTAL PROCEDURES 
Protein expression and purification 
pCMV6 containing the full-length mouse Bok cDNA (NM_016778.3) was purchased from Origene 
(SKU: MC206561, Rockville, MD, US). The Bok CDS was cloned into the SapI restriction sites of 
the pTXB1 plasmid (New England Biolabs, Ipswich, MA, US), containing the intein-chitin binding 
domain tag, according to the manufacturer’s instructions and sequences confirmed (Microsynth, 
Balgach, CH). A truncated version of BOK lacking the C-terminal 24 amino acids (BOK∆C) was 
created by PCR using the primers 5’-TGCATCACGGGAGATGCA-3’ and 5’-
GTGGGAGCGGAAGCCAGGA-3’. A five-liter culture of BL21-CodonPlus (DE3)-RIPL E. coli 
strain (Agilent Technologies, Santa Clara, CA, US) harboring the pTXB1-BOK∆C construct was 
prepared in selective Terrific Broth media (100 µg/mL Ampicillin, 30 µg/mL Chloramphenicol) and 
protein expression was induced at 20°C for 5h with 1 mM IPTG. The bacterial pellet was collected, 
resuspended in Chitin Buffer (1 M NaCl, 20 mM Tris-HCl, pH 8.5) supplemented with Complete 
Protease Inhibitor Cocktail® (Roche Diagnostics AG, Rotkreuz, CH) and disrupted at 11’000 p.s.i in 
an Emulsiflex-C5 homogenizer (AVESTIN Europe GmbH, Mannheim, DE). The lysate was cleared 
and recombinant BOK∆C captured with chitin-beads (New England Biolabs, GB), followed by DTT-
induced intein autolysis during 16h at 4°C. The protein was eluted, dialyzed and further purified by a 
cation-exchange chromatography using a HiTrap SP FF column (GE Healthcare, GE). Purity, yield, 
and protein identity were assessed by densitometric analysis of Coomassie stained SDS-PAGE gels 
using ImageJ [44], protein quantification using the Bradford reagent, western blot (using an in-house 
rabbit monoclonal anti-BOK antibody, RabMab BOK-1-5 [12]) and mass spectrometry respectively. 
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Protein purity was >90% (see also Figure 1B, D), except for studies of the influence of the lipid 
composition BOK membrane activity (Figure 2) where a slightly less pure batch of BOK∆C was used. 
Cleaved cBID (complex of fragments p7 and p15), BAX and BCL-XL were expressed in E.coli and 
purified as previously described [4, 23, 30].  
 
Preparation of artificial membranes 
All the lipids used in this study were purchased from Avanti Polar Lipids (Hamburg, DE), 
resuspended in chloroform and mixed at the indicated ratios (w/w). LUVs were prepared as described 
elsewhere [45]. Briefly, each lipid mixture was vacuum dried and resuspended in a solution of 80 mM 
calcein, pH 7.0 to a final concentration of 4 mg/mL followed by 5 cycles of freeze/thawing in liquid 
nitrogen. The resulting multilamellar vesicles were extruded 31 times through a 400 µm 
polycarbonate membrane using a LiposoFast manual emulsifier (AVESTIN Europe GmbH, 
Mannheim, DE). The non-encapsulated calcein was removed from the mixture using a Sephadex-G50 
column previously equilibrated with DPBS from Sigma. Special lipid mixtures modelling the 
composition of the mitochondrial membrane (MITOmix; PS:CL:PI:PC:PE, 10:8:11:46:25) [23] or the 
endoplasmic reticulum (ERmix; Sph:PS:PI:PC:PE, 4:4:10:57:25) [46] were prepared according to the 
reported composition. GUVs were prepared as previously described [33]. Shortly, 5 µL of a 1 mg/mL 
lipid-chloroform solution containing the dye Dil (<0.05%; Thermofisher) was layered in two platinum 
electrodes, air dried and immersed in a Teflon chamber containing 300 mM sucrose. The electrodes 
were wired to a function generator power source and the GUVs were electro-formed by sequential 
application of 10 Hz, for 2 h and 2 Hz for 30 min.  
 
Calcein release assay 
Calcein-loaded LUVs were incubated with serial dilutions of the recombinant proteins or BH3 
peptides corresponding to BIM or BID proteins in a fluorescent-compatible 96-well microtiter plate 
(NUNC). Calcein release was monitored by fluorescence emission at 520 nm (λexcitation= 495 nm) 
during two hours in an Infinite M200 plate reader (Tecan, Mainz, DE). The percentage dye release 
was calculated as follows: 
 ܥ݈ܽܿ݁݅݊௥௘௟௘௔௦௘	(%	݋݂max) 	= 100 ∗ (ி
ೄೌ೘೛೗೐ିிಳೠ೑೑೐ೝ)
(ி೅೉భబబିிಳೠ೑೑೐ೝ) , were all the terms refer to the maximum 
fluorescence registered in the wells incubated with the studied proteins (FSample), with 0.125% Triton-
X100 (FTX100) or DPBS (FBuffer). The maximum values were obtained by curve fitting to a hyperbole 
or, in those cases where calcein self-quenched due to a massive release, it was assigned to the 
maximum value before the quenching started. The effective concentration of BOK∆C was corrected 
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between batches according to the individual EC50 values. The sequences for the BH3 peptides are the 
following: BID-BH3(IARHLAQVGDSMD), BIM-BH3(IAQELRRIGDEFN).  
 
GUVs permeabilisation experiments 
GUVs permeabilisation assays were performed according to [23]. Briefly, 70 µL of GUVs made from 
MITOmix were incubated at 25°C for 1 h in a casein-coated LabTec chamber (NUNC) containing cyt. 
c488, APC and the studied proteins dissolved in DPBS. The total volume in each reaction chamber is 
300 µL. After the incubation time at least five pictures of each condition were taken using a LSM710 
microscope with a C-Apochromat 40 1.2 water immersion objective (Zeiss, Oberkochen, DE). A 
similar setup was prepared for the heat activation of BOK∆C in GUVs, just setting the reaction 
temperature to 42°C for 45 min, before allowing the samples to cool down to RT before the pictures 
were taken. The evaluation of the pore stability was adapted from Bleicken et al. [30]. Shortly, GUVs 
were incubated for 45 min at RT with or without the indicated BCL-2 proteins in DPBS containing 
AF555 as an indicator of the permeabilisation status of the vesicles. Afterwards, cyt. c488 and APC 
were added to the mixture and the pictures were taken 15 min later.  For each experiment, the GUVs 
permeabilisation degree to the analyzed dyes was determined using the GUVs detector software 
available at http://www.ifib.uni-tuebingen.de/research/garcia-saez/GUVs-software.html [47]. The 
threshold for considering a GUV permeated was arbitrarily set at 30% with the exception of the pore 
stability assays where it was set up to 50 %, 35% and 40% for AF555, cyt. c488 and APC respectively. 
Data was analyzed using R version 3.2.1 [48] and visualized using the ggplot2 package [49]. 
 
Mitochondria isolation 
Cell cultures in exponential growth phase of Bax-/-Bak-/- SV40 large T antigen immortalized mouse 
embryo fibroblasts (SV40 MEF) were trypsinized, washed with DPBS and incubated for 15 minutes 
in MB buffer (210 mM mannitol, 70 mM sucrose, 1 mM EDTA, 10 mM HEPES pH 7,5 
supplemented with Complete Protease Inhibitor Cocktail (Roche, CH). The cells were manually 
disrupted by 18 passages through a 27 G needle, and the debris was removed by centrifugation at 
2’500 x g (3 x 5 min). The mitochondria-enriched fraction was obtained by centrifugation for 10 min 
at 10’ 000 x g, resuspended in MB-EGTA buffer (MB buffer with 1 mM EGTA instead of EDTA) 
and its protein concentration determined by Bradford assay (Biorad, Cressier, CH). The mitochondrial 
preparations were immediately used for the cytochrome c release assays.  
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Cytochrome c release assays 
Cytochrome c release from mitochondria was performed as previously reported [50]. Briefly, 30 µg of 
mitochondria were incubated with the following protein amounts unless indicated otherwise (100 nM 
BOK∆C, 50nM cBID, 100 nM BAX) in KCL buffer (125 mM KCl, 4 mM MgCl2, 5 mM KH2PO4, 10 
mM HEPES pH 7,4, 0,5 mM EGTA) for 60 min at 37 °C. The supernatant was collected and the 
pellet was washed with KCl buffer, followed by addition of Laemmli buffer. For the experiments 
using heat-activated BOK∆C, we proceeded as described by [31] with minor modifications. Shortly, 
the recombinant proteins were heated at 43°C for 1 h in the presence of the isolated mitochondria in 
KCL buffer. Pellet and supernatant were separated afterwards by centrifugation. The presence of cyt. 
c in the fractions was determined by western blotting using a mouse monoclonal anti-cyt. c antibody 
(BD Biosciences, clone 7H8.2C12). 
 
Membrane binding assays. 
Crude mitochondria preparations from Bok-/- SV40 MEF were incubated with the indicated 
combinations of recombinant proteins (200 nM BOK∆C, 100nM cBID) at 37°C for 1 h. Afterwards the 
samples were fractionated by centrifugation or linear sucrose gradient (1-2M). The samples processed 
by sucrose gradient were ultracentrifuged at 50’000 x g in a swinging bucket SW41 rotor (Beckman 
Coulter, Nyon, CH) during 90 min. The gradients were then split in 1 mL fractions and precipitated 
using methanol/ chloroform. The distribution of the recombinant proteins across the gradient was 
detected by western blotting using the corresponding antibodies:  rabbit monoclonal anti BOK 
(RabMab BOK-1-5 [12]), rabbit polyclonal anti-BAX (Santa Cruz Biotechnology, sc-493), mouse 
monoclonal anti-porin (Calbiochem, clone 89-173/016). 
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FIGURE 1. Purification of recombinant BOK∆C using a two-step affinity-based strategy. (A) 
Predicted isoelectric point of multidomain BCL-2 family members (based on Expasy Compute pI/Mw 
tool, http://web.expasy.org/compute_pi/). (B) Representative coomassie stained SDS-PAGE gel 
evaluating the purification process of recombinant BOK. Beads: 10 µL of chitin beads after lysate 
input and before DTT-induced intein cleavage, CEX: cation affinity chromatography. (C) Inmunoblot 
of the same samples from panel B using a rabbit monoclonal anti-BOK antibody. (D) Purification 
tables for a typical production of recombinant BOK∆C. 
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FIGURE 2. The lipid composition modulates the permeabilisation potential of BOK∆C. Several 
lipid mixtures were used to determine the influence on BOK∆C -mediated permeabilisation of: (A) 
vesicles mimicking mitochondria (MITOmix) or endoplasmic reticulum (ERmix), (B) negatively 
charged lipids (CL), (C) positive curvature inducers (LPC) and (D) non-lamellar compatible lipids 
(PA) together with a neutral negative curvature inducer lipid (Chol). Lipid ratios are indicated for 
each composition as molar percentages. Calcein release was normalized to the maximum release 
induced by Triton-X100 on each sample.  PC:phosphatidylcholine, CL: cardiolipin, PG: 
phosphatidylglycerol, LPC: lyso-phosphatidylcholine, PA:phosphatidic acid, Chol: cholesterol. 
Values correspond to mean ± SEM; N=3. 
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FIGURE 3. BOK∆C -mediated vesicle permeabilisation is enhanced by cBID and allows the 
passage of molecules of up to 104 kDa. (A) Determination of EC50 value for BOK∆C in PC:CL 80:20 
vesicles. (B) Calcein release from PC:CL 80:20 liposomes using BOK∆C at the EC50 concentration and 
variable amounts of cBID or (C) increasing concentration of BH3 peptides. Dashed lines represents 
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the maximum calcein release promoted by 100 nM cBID, 0.1 µM full length BOK ± 50 nM cBID or 1 
µM of the indicated BH3 peptides. (D) Fraction of non-permeabilized GUV to cyt. c488 (12 kDa) or 
APC (104 kDa) 60 min after treatment with different combinations of cBID (10 nM), BOK∆C (10 
nM), BCL-XL (50 nM) and BAX (20 nM). Bars correspond to mean ± SEM; N=3. (E) Percentage of 
filling degree to the indicated fluorescent proteins for each individual vesicle across the indicated 
treatments. The percentage of GUV on each quadrant is indicated. Statistical differences were 
calculated with a two-way ANOVA correcting the p-values using the Benjamini-Krieger-Yekutieli 
method. Shared letters indicate non-significant differences with p-values of at least 0.05.  
 
FIGURE 4. BOK∆C can be activated by temperature. (A) Percentage of non-permeabilized 
MITOmix-derived GUVs to cyt. c488 and APC after incubation at 42°C for 45 min with 20 nM BAX 
or 10 nM BOK. Bars correspond to mean ± SEM; N=3. (B) Percentage of filling degree to the 
indicated fluorescent proteins for each individual vesicle across the treatments. The percentage of 
GUV on each quadrant is indicated. Statistical differences were calculated with a two-way ANOVA 
correcting the p-values using the Benjamini-Krieger-Yekutieli method. Shared letters indicate non-
significant differences with p-values of at least 0.05. 
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FIGURE 5. Pores formed by BOK∆C are stable over time.  (A) Representative pictures for the 
MITOmix-made GUV incubated during 45 min with the indicated proteins in the presence of AF555, 
followed by addition of cyt. c488 and APC. Bars represent 50 µm. (B) Determination of the AF555 
degree of incorporation into the GUV using a filling threshold of 50%. (C) Number of GUV per area 
across the treatments. (D) Filling degree to cyt. c488 and APC in those GUVs already filled with 
AF555 (>50%). (E) Percentage of filling degree to the indicated fluorescent proteins on each 
individual vesicle across the samples. Whiskers cover 10th-90th percentile; N=4. Statistical differences 
were calculated with a one-way (B, C) or two-way ANOVA correcting the p-values using the 
Benjamini-Krieger-Yekutieli method. Shared letters indicate non-significant differences with p-values 
of at least 0.05. 
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FIGURE 6. Binding of BOK∆C to isolated BAX/BAK-deficient mitochondria is not sufficient for 
cytochrome c release. Mitochondria isolated from Bax-/-Bak-/- (A, B) or Bok-/- (C, D) SV40 MEF 
were incubated during 1 h at 37°C (A, C, D) or 43°C (B) with combinations of 50 nM cBID, 100 nM 
BOK∆C or 100 nM BAX; unless indicated otherwise. The release of cytochrome c (A, B) was assessed 
immediately after the assay by immunoblotting of pellet (mitochondria) and supernatant fractions, 
respectively. (C) BOK∆C interacts with membranes in mitochondrial preparation independent of the 
presence of cBID. (D) BOK∆C interacts with intracellular membranes not restricted to mitochondria 
and irrespective of the presence of cBID. Presented data is representative of at least 3 independent 
experiments.  
 
 
 
 
